Iwona Brzosko

415 total citations
28 papers, 276 citations indexed

About

Iwona Brzosko is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Iwona Brzosko has authored 28 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Rheumatology, 8 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Iwona Brzosko's work include Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). Iwona Brzosko is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). Iwona Brzosko collaborates with scholars based in Poland, Russia and Germany. Iwona Brzosko's co-authors include Marek Brzosko, Lidia Ostanek, Andrzej Pawlik, Marek Masiuk, Bogusław Machaliński, B Gawrońska-Szklarz, Hanna Przepiera‐Będzak, Katarzyna Fischer, Marcin Sawicki and Anna Walecka and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Pharmacology & Therapeutics and Lara D. Veeken.

In The Last Decade

Iwona Brzosko

26 papers receiving 264 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iwona Brzosko Poland 8 146 125 39 30 30 28 276
Lidia Ostanek Poland 9 154 1.1× 139 1.1× 47 1.2× 28 0.9× 35 1.2× 39 296
Izumi Kurata Japan 10 107 0.7× 119 1.0× 41 1.1× 23 0.8× 23 0.8× 19 268
Alicia Eimon Argentina 9 186 1.3× 170 1.4× 51 1.3× 44 1.5× 18 0.6× 14 317
K. Veres Hungary 7 214 1.5× 170 1.4× 40 1.0× 13 0.4× 64 2.1× 11 333
Ivana Nieto‐Aristizábal Colombia 9 188 1.3× 130 1.0× 28 0.7× 23 0.8× 29 1.0× 32 295
TRDJ Radstake Netherlands 10 118 0.8× 97 0.8× 43 1.1× 52 1.7× 47 1.6× 20 268
A. Balanescu Romania 10 138 0.9× 163 1.3× 68 1.7× 31 1.0× 17 0.6× 47 340
Concepción Moll Spain 7 195 1.3× 105 0.8× 44 1.1× 53 1.8× 41 1.4× 12 342
Katie Stewart United States 9 99 0.7× 101 0.8× 74 1.9× 19 0.6× 25 0.8× 14 295
Yosuke Kunishita Japan 9 212 1.5× 89 0.7× 76 1.9× 35 1.2× 40 1.3× 20 308

Countries citing papers authored by Iwona Brzosko

Since Specialization
Citations

This map shows the geographic impact of Iwona Brzosko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwona Brzosko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwona Brzosko more than expected).

Fields of papers citing papers by Iwona Brzosko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwona Brzosko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwona Brzosko. The network helps show where Iwona Brzosko may publish in the future.

Co-authorship network of co-authors of Iwona Brzosko

This figure shows the co-authorship network connecting the top 25 collaborators of Iwona Brzosko. A scholar is included among the top collaborators of Iwona Brzosko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwona Brzosko. Iwona Brzosko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wójcik, Krzysztof, Anna Masiak, Iwona Brzosko, et al.. (2022). Association of antineutrophil cytoplasmic antibody (ANCA) specificity with the demographic and clinical characteristics of patients with ANCA-associated vasculitides. Polskie Archiwum Medycyny Wewnętrznej. 132(3). 4 indexed citations
2.
3.
Wójcik, Krzysztof, Anna Masiak, Zbigniew Zdrojewski, et al.. (2021). AB0820 INFLUENCE OF ANCA ANTIBODIES ON DEMOGRAPHIC AND CLINICAL CHARACTERISTIC OF AAV. Annals of the Rheumatic Diseases. 80. 1434–1434. 1 indexed citations
4.
Wójcik, Krzysztof, Adam Ćmiel, Anna Masiak, et al.. (2020). FRI0223 SUBPHENOTYPES OF ANCA ASSOCIATED VASCULITIS IDENTIFIED BY LATENT CLASS ANALYSIS. Annals of the Rheumatic Diseases. 79. 694–695. 1 indexed citations
5.
Fischer, Katarzyna, Hanna Przepiera‐Będzak, Marcin Sawicki, et al.. (2017). Serum Interleukin-23 in Polish Patients with Systemic Lupus Erythematosus: Association with Lupus Nephritis, Obesity, and Peripheral Vascular Disease. Mediators of Inflammation. 2017. 1–9. 28 indexed citations
6.
Przepiera‐Będzak, Hanna, et al.. (2012). The imaging of sterno-clavicular joints in SAPHO syndrome. Postępy Nauk Medycznych. 1 indexed citations
7.
Przepiera‐Będzak, Hanna, et al.. (2010). [Cardiovascular manifestations of seronegative inflammatory spondyloarthropathies].. PubMed. 56 Suppl 1. 62–5. 3 indexed citations
8.
Brzosko, Iwona, et al.. (2007). Morfologia głośni w reumatoidalnym zapaleniu stawów. Otolaryngologia Polska. 61(1). 85–90. 2 indexed citations
9.
Kaźmierczak, Jarosław, Małgorzata Peregud‐Pogorzelska, Jowita Biernawska, et al.. (2007). Cardiac Arrhythmias and Conduction Disturbances in Patients With Ankylosing Spondylitis. Angiology. 58(6). 751–756. 24 indexed citations
10.
Przepiera‐Będzak, Hanna, et al.. (2006). [SAPHO syndrome--clinical features].. PubMed. 116(6). 1172–7. 2 indexed citations
11.
Pawlik, Andrzej, et al.. (2005). TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.. PubMed. 34(1). 22–6. 25 indexed citations
12.
Brzosko, Iwona, et al.. (2004). [Fixation of the crico-arythenoid joints in rheumatoid arthritis--preliminary report].. PubMed. 58(4). 843–9. 5 indexed citations
13.
Brzosko, Iwona, Marek Brzosko, Marek Droździk, et al.. (2004). The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab. Clinical Rheumatology. 23(3). 214–217. 7 indexed citations
14.
Pawlik, Andrzej, et al.. (2004). The influence of N-acetyltransferase 2 polymorphism on rheumatoid arthritis activity.. PubMed. 22(1). 99–102. 3 indexed citations
15.
Pawlik, Andrzej, Lidia Ostanek, Iwona Brzosko, et al.. (2003). The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Research & Therapy. 5(4). R210–3. 96 indexed citations
16.
Pawlik, Andrzej, Lidia Ostanek, Iwona Brzosko, et al.. (2003). Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatology International. 24(6). 351–354. 18 indexed citations
17.
Pawlik, Andrzej, et al.. (2003). FC gamma RIIa polymorphism in patients with rheumatoid arthritis.. PubMed. 20(6). 841–4. 7 indexed citations
18.
Pawlik, Andrzej, et al.. (2002). Increased genotype frequency of N‐acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 72(3). 319–325. 14 indexed citations
19.
Brzosko, Iwona, et al.. (1998). Value of platelet factor 4 and beta thromboglobulin determination in plasma of patients with systemic lupus erythematosus. Medical Science Monitor. 4(5). 1 indexed citations
20.
Brzosko, Marek, et al.. (1997). Effects of ionic and non-ionic contrast media on platelet function as evaluated by plasma concentration of beta-thromboglobulin.. British Journal of Radiology. 70(840). 1239–1244. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lidia Ostanek Breakdown of academic impact, for papers by Izumi Kurata Breakdown of academic impact, for papers by Alicia Eimon Breakdown of academic impact, for papers by K. Veres Breakdown of academic impact, for papers by Ivana Nieto‐Aristizábal Breakdown of academic impact, for papers by TRDJ Radstake Breakdown of academic impact, for papers by A. Balanescu Breakdown of academic impact, for papers by Concepción Moll Breakdown of academic impact, for papers by Katie Stewart Breakdown of academic impact, for papers by Yosuke Kunishita
Rankless by CCL
2026